R&D From pilots to patients: Why the UK must rethink NHS innovat... At PharmaTech Integrates in Glasgow, speakers from government, academia, the NHS, and pharma sought to define the sector’s path forward.
R&D The UK can’t just be a life sciences lab – we need manufactu... Rachel Reeves is right: the UK is at the forefront of life sciences, with some world-leading research and innovation.
R&D From promise to reality: Unlocking the true business potenti... The genomic medicine space has seen incredible success, but investors are overlooking it.
Patients How prioritising sustainability efforts yields long-term gro... The pharmaceutical industry is at a pivotal juncture.
Market Access US-Chinese relations put the brakes on biotech cooperation The China-US trade war has spread to the biotech industry, as the US BIOSECURE Act looks to dampen Chinese influence on a range of services, including contract manufacturing.
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.